Literature DB >> 9464281

Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts.

A Miyamoto1, T Kunisada, H Hemmi, T Yamane, H Yasuda, K Miyake, H Yamazaki, S I Hayashi.   

Abstract

Osteoclasts are hematopoietic cells essential for bone remodeling and resorption. To understand the process of osteoclast development, we established a macrophage-like cell line C7 that has the potential to differentiate into functional osteoclasts; multinuclear tartrate-resistant acid phosphatase positive cells capable of forming pits on dentin slices. C7 cells share the characteristics of their cell surface molecules and phagocytic activity with macrophages. Generation of osteoclasts from C7 cells was mostly suppressed by the addition of a function-blocking antibody directed to c-Fms, the receptor for macrophage-colony stimulating factor (M-CSF), or by osteoclastogenesis inhibitory factor (OCIF). These responses correspond well with the osteoclast precursors present in bone marrow and peritoneal cavity. Reagents such as bacterial lipopolysaccharide and granulocyte/macrophage-CSF that are known to act as inducers for other cell lineages rather than osteoclasts abolished the potential of osteoclastogenesis in C7 cells. These phenotypes of C7 cells have been stably maintained for more than 2 years. We believe that the cell line established in this study will provide an important tool for osteoclast biology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464281     DOI: 10.1006/bbrc.1997.8046

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma.

Authors:  Masahiro Abe
Journal:  Int J Hematol       Date:  2011-10-18       Impact factor: 2.490

2.  Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.

Authors:  N Ogata; D Chikazu; N Kubota; Y Terauchi; K Tobe; Y Azuma; T Ohta; T Kadowaki; K Nakamura; H Kawaguchi
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 4.  Peripheral Blood Mononuclear Cells (PBMCs) to Dissect the Underlying Mechanisms of Bone Disease in Chronic Kidney Disease and Rare Renal Diseases.

Authors:  Irma Machuca-Gayet; Justine Bacchetta; Julie Bernardor; Candide Alioli; Marie-Noelle Meaux; Olivier Peyruchaud
Journal:  Curr Osteoporos Rep       Date:  2021-11-13       Impact factor: 5.096

5.  Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production.

Authors:  Masahiro Abe; Kenji Hiura; Shuji Ozaki; Shinsuke Kido; Toshio Matsumoto
Journal:  J Bone Miner Metab       Date:  2008-12-05       Impact factor: 2.626

Review 6.  The TNF receptor superfamily: role in immune inflammation and bone formation.

Authors:  Xin Cheng; Masa Kinosaki; Ramachandran Murali; Mark I Greene
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

7.  Macrophage inflammatory protein-1alpha (MIP-1alpha) enhances a receptor activator of nuclear factor kappaB ligand (RANKL) expression in mouse bone marrow stromal cells and osteoblasts through MAPK and PI3K/Akt pathways.

Authors:  Masanobu Tsubaki; Chisato Kato; Miyuki Manno; Mitsuhiko Ogaki; Takao Satou; Tatsuki Itoh; Takashi Kusunoki; Yoshihiro Tanimori; Kimiko Fujiwara; Hiroshi Matsuoka; Shozo Nishida
Journal:  Mol Cell Biochem       Date:  2007-06-05       Impact factor: 3.396

Review 8.  Modulation of Osteoclast Interactions with Orthopaedic Biomaterials.

Authors:  Chris Steffi; Zhilong Shi; Chee Hoe Kong; Wilson Wang
Journal:  J Funct Biomater       Date:  2018-02-26

9.  Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation.

Authors:  Masanobu Tsubaki; Makiko Komai; Tatsuki Itoh; Motohiro Imano; Kotaro Sakamoto; Hirotaka Shimaoka; Tomoya Takeda; Naoki Ogawa; Kenji Mashimo; Daiichiro Fujiwara; Junji Mukai; Katsuhiko Sakaguchi; Takao Satou; Shozo Nishida
Journal:  J Biomed Sci       Date:  2014-02-03       Impact factor: 8.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.